Cell-cycle arrest and acute kidney injury: The light and the dark sides

Nephrology Dialysis Transplantation

Volumn 31, Issue 1, 2016, Pages 16-22

  Kellum, John A ^a   Chawla, Lakhmir S ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

acute kidney injury; cell cycle arrest; insulin like growth factor binding protein 7; tissue inhibitor of metalloproteinases 2

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYCLOSPORIN A; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; SOMATOMEDIN BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; TIMP2 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; APOPTOSIS; CELL CYCLE ARREST; CELL DAMAGE; CELL DIVISION; CELL PROTECTION; CREATININE BLOOD LEVEL; HUMAN; MULTICENTER STUDY (TOPIC); NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RENAL PROTECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; SINGLE DRUG DOSE; ACUTE KIDNEY INJURY; ANIMAL; CELL CYCLE CHECKPOINT; DISEASE COURSE; PATHOLOGY; URINE;

ACUTE KIDNEY INJURY; ANIMALS; BIOMARKERS; CELL CYCLE CHECKPOINTS; DISEASE PROGRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84959035943     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv130     Document Type: Review

References (40)

1. Kellum JA, Bellomo R, Ronco C. Kidney attack. JAMA 2012; 307: 2265-2266
2. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012; 380: 756-766
3. Chawla LS, Amdur RL, Shaw AD, et al. Association between AKI and longterm renal and cardiovascular outcomes in United States veterans. Clin J Am Soc Nephrol 2014; 9: 448-456
4. Wu V-C, Wu C-H, Huang T-M, et al. Long-Term risk of coronary events after AKI. J Am Soc Nephrol 2014; 25: 595-605
5. Hoste EAJ, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10: R73
6. Murugan R, Karajala-Subramanyam V, Lee M, et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 2010; 77: 527-535
7. Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-Term mortality after cardiothoracic surgery. Circulation 2009; 119: 2444-2453
8. Chawla LS, Eggers PW, Star RA, et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 2014; 371: 58-66
9. Kheterpal S, Tremper KK, Heung M, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 2009; 110: 505-515
10. KDIGO AKIWG. Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Inter 2012; 2 (Suppl): 1-138. 2012: 1-141
11. Bell M, Granath F, Mårtensson J, et al. Cystatin C is correlated with mortality in patients with and without acute kidney injury. Nephrol Dial Transplant 2009; 24: 3096-3102
12. Mehta RL, Pascual MT, Gruta CG, et al. Refining predictivemodels in critically ill patients with acute renal failure. J Am Soc Nephrol 2002; 13: 1350-1357
13. Kellum JA, Devarajan P. What can we expect from biomarkers for acute kidney injury?. Biomark Med 2014; 8: 1239-1245
14. Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17: R25
15. Wetz AJ, Richardt EM, Wand S, et al. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?. Critical Care 2015; 19: 915
16. Yamashita T, Doi K, Hamasaki Yet al. Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study. Crit Care 2014; 18: 716
17. Hoste EAJ, McCullough PA, Kashani K, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 2014; 29: 2054-2061
18. Bihorac A, Chawla LS, Shaw AD, et al.Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014; 189: 932-939
19. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818
20. Nisula S, Kaukonen KM, Vaara ST. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med 2013; 39: 420-428
21. Price PM, Safirstein RL, Megyesi J. The cell cycle and acute kidney injury. Kidney Int 2009; 76: 604-613
22. Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004; 337: 1-13
23. Seo D-W, Li H, Qu C-K, et al. Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J Biol Chem 2006; 281: 3711-3721
24. Zuo S, Liu C, Wang J, et al. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells. J Cancer Res Clin Oncol 2012; 138: 1045-1055
25. Meersch M, Schmidt C, Van Aken H, et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One 2014; 9: e93460
26. Shankland SJ. Cell cycle regulatory proteins in glomerular disease. Kidney Int 1999; 56: 1208-1215
27. Preisig PA, Franch HA. Renal epithelial cell hyperplasia and hypertrophy. Semin Nephrol 1995; 15: 327-340
28. Yang L, Besschetnova TY, Brooks CR, et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543
29. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J Cell Biochem 1995; 58: 160-174
30. Megyesi J, Safirstein RL, Price PM. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 1998; 101: 777-782
31. Witzgall R, Brown D, Schwarz C, et al. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994; 93: 2175-2188
32. Wang Z, Famulski K, Lee J, et al. TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury. Kidney Int 2014; 85: 82-93
33. Ahmed AK, Nahas El AM, Johnson TS. Changes in matrix metalloproteinases and their inhibitors in kidney transplant recipients. Exp Clin Transplant 2012; 10: 332-343
34. Koyner JL, Shaw AD, Chawla LS, et al. Tissue Inhibitor Metalloproteinase-2 (TIMP-2) and IGF-Binding Protein-7 (IGFBP7) levels are associated with adverse long-Term outcomes in patients with AKI. J Am Soc Nephrol 2015; 26: 1747-1754
35. Aregger F, Uehlinger DE, Witowski J, et al. Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury. Kidney Int 2013; 85: 909-919
36. Jaeschke H. Mechanisms of Liver Injury II. Am J Physiol Gastro Liver Physiol 2006; 290: G1083-8
37. Peng Z, Zhou F, Wen X, et al. Single dose of cyclosporine protects against sepsis-induced acute kidney injury in rats. Crit Care Med 2012; 40: 209. (Abtract
38. Wen X, Peng Z, Li Y, et al. One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in mice. Nephrol Dial Transplant 2012; 27: 3100-3109
39. Gomez H, Ince C, De Backer D, et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014; 41: 3-11
40. Endre ZH, Pickering JW. Acute kidney injury: cell cycle arrest biomarkers win race for AKI diagnosis. Nat Rev Nephrol 2014; 10: 683-685